TaiwanSociety of Cardiology Registry on Heart Failure with Reduced Ejection Fraction(TSOC-HFrEF registry)

TSOC-HFRegistry

–Characteristics at Admission

TSOC-HFRegistry

–Primary Etiology of HF

TSOC-HFRegistry

–Intravenous drugs andinterventions

TSOC-HFRegistry

–Median Length of Stay

Heartfailure in Taiwan: length of stay

TSOC-HFRegistry

–In-Hospital Mortality

TSOC-HFRegistry

–TSOC-HFrEF outcomes

GDMTat discharge

Trendsin oral medication over time

GDMT: Prescription & Outcomes

Post-discharge survival rates of HF patients: Cardiologistsvs. GPs, vs. others

Compliance with treatment guideline reduced the need forre-hospitalization

Recommendationsfor Biomarkers in HF

Useof Biomarker in HF: Tx.guidance

PARADIGM-HF 试验——高ST2浓度对应更多不良事件

ST2 Predicts Prognosis in Val-HeFT

治疗 1个月和 8个月时的ST2值

基于35 ng/mL阈值观察治疗前后病人ST2变化

ST2 Predicts Prognosis in PROTECT

根据治疗前后 ST2 变化——预测对于治疗的反应: RAAS blockers

根据治疗前后 ST2 变化——预测对于治疗的反应: diuretics

根据治疗前后 ST2 变化——预测对于治疗的反应: β-blocker

基线ST2水平和 β-blocker 剂量——影响心血管事件

Patientinertia

Adherence to self-care behaviors among HF patients

Patientinertia

Promotepatient self-care

Patientand caregiver

Supporting systems

How to improve the situation ?

What else ?

Multi-disciplinary team approach for the management of HF patients

Post-acutecare

Palliation ≠ Ignoration

Heart Failure Fact Sheet

Preventing HF, HF worsening, and HFdeath

中华民国心脏基金会发表

Until… a world with better primary and secondary preventionof heart failure!